VI
FLGT icon

Versor Investments’s Fulgent Genetics FLGT Stock Holding History

Versor Investments’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-16,493
Closed -$477K – 746
2023
Q4 		$477K Sell
16,493
-6,887
-29% -$184K 0.1% 349
2023
Q3 		$625K Buy
23,380
+15,167
+185% +$518K 0.13% 229
2023
Q2 		$304K Sell
8,213
-10,228
-55% -$357K 0.05% 415
2023
Q1 		$576K Buy
18,441
+8,816
+92% +$284K 0.08% 275
2022
Q4 		$287K Sell
9,625
-24,535
-72% -$878K 0.02% 526
2022
Q3 		$1.3M Buy
34,160
+13,962
+69% +$700K 0.08% 159
2022
Q2 		$1.1M Buy
20,198
+7,892
+64% +$434K 0.04% 217
2022
Q1 		$768K Buy
+12,306
New +$810K 0.03% 195

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Versor Investments's FLGT Position: Q1 2024 in Review

Versor Investments sold out of Fulgent Genetics (FLGT) in Q1 2024, closing a stake of 16,493 shares — an estimated $477K sold.

Versor Investments first reported a position in FLGT in Q1 2022 and held it in 8 quarters. The position peaked at $1.3M in Q3 2022. 180 funds tracked by Wall St. Rank hold FLGT as of Q1 2024.

  • Versor Investments reported no remaining Fulgent Genetics position as of Q1 2024 after selling out during the quarter.
  • Versor Investments sold 16,493 Fulgent Genetics shares in Q1 2024, an estimated $477K.
  • Versor Investments first reported a position in Fulgent Genetics in Q1 2022 and held it in 8 quarters.
  • Versor Investments's Fulgent Genetics position peaked at $1.3M in Q3 2022.
  • 180 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2024.

Based on Versor Investments's 13F filing for Q1 2024, filed 13 May 2024.